ZC2HC1B
gene geneOn this page
Also known as dJ468K18.5
Summary
ZC2HC1B (zinc finger C2HC-type containing 1B, HGNC:21174) is a protein-coding gene on chromosome 6q24.2, encoding Zinc finger C2HC domain-containing protein 1B (Q5TFG8).
Predicted to enable zinc ion binding activity.
Source: NCBI Gene 153918 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_001013623
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21174 |
| Approved symbol | ZC2HC1B |
| Name | zinc finger C2HC-type containing 1B |
| Location | 6q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ468K18.5 |
| Ensembl gene | ENSG00000118491 |
| Ensembl biotype | protein_coding |
| Entrez | 153918 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000237275, ENST00000539295
RefSeq mRNA: 1 — MANE Select: NM_001013623
NM_001013623
CCDS: CCDS47495
Canonical transcript exons
ENST00000237275 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001620516 | 143938142 | 143938343 |
| ENSE00003553684 | 143884304 | 143884365 |
| ENSE00003588160 | 143886032 | 143886151 |
| ENSE00003591001 | 143864474 | 143864567 |
| ENSE00003654836 | 143886683 | 143886821 |
| ENSE00003755440 | 143937649 | 143937733 |
| ENSE00003755770 | 143898552 | 143898691 |
| ENSE00003757639 | 143903044 | 143903152 |
Expression profiles
Bgee: expression breadth broad, 64 present calls, max score 92.17.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0434 / max 34.7335, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 70270 | 0.0363 | 3 |
| 70271 | 0.0044 | 3 |
| 70269 | 0.0027 | 2 |
Top tissues by expression
92 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.17 | silver quality |
| left testis | UBERON:0004533 | 81.49 | gold quality |
| testis | UBERON:0000473 | 80.92 | gold quality |
| right testis | UBERON:0004534 | 79.81 | gold quality |
| placenta | UBERON:0001987 | 49.22 | gold quality |
| ventricular zone | UBERON:0003053 | 45.74 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 43.50 | gold quality |
| bone marrow cell | CL:0002092 | 42.86 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 42.58 | silver quality |
| vermiform appendix | UBERON:0001154 | 42.53 | gold quality |
| colonic epithelium | UBERON:0000397 | 42.38 | gold quality |
| muscle tissue | UBERON:0002385 | 41.62 | gold quality |
| calcaneal tendon | UBERON:0003701 | 41.53 | gold quality |
| endometrium | UBERON:0001295 | 41.41 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 41.25 | gold quality |
| lymph node | UBERON:0000029 | 40.76 | gold quality |
| skin of abdomen | UBERON:0001416 | 39.41 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 39.10 | gold quality |
| lower esophagus | UBERON:0013473 | 38.92 | gold quality |
| sural nerve | UBERON:0015488 | 38.68 | gold quality |
| tonsil | UBERON:0002372 | 38.38 | silver quality |
| apex of heart | UBERON:0002098 | 37.73 | silver quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 37.32 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 37.04 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 37.03 | gold quality |
| zone of skin | UBERON:0000014 | 36.71 | gold quality |
| esophagus | UBERON:0001043 | 36.63 | gold quality |
| monocyte | CL:0000576 | 36.53 | silver quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| endocervix | UBERON:0000458 | 36.21 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.99 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting ZC2HC1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-6772-5P | 99.94 | 67.01 | 577 |
| HSA-MIR-3140-3P | 99.88 | 68.47 | 2069 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-155-5P | 99.35 | 70.16 | 1509 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-6734-3P | 99.15 | 66.27 | 1627 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-6754-5P | 98.60 | 65.54 | 1627 |
| HSA-MIR-3977 | 98.00 | 68.17 | 1500 |
| HSA-MIR-6815-5P | 96.05 | 65.55 | 662 |
| HSA-MIR-6865-5P | 96.05 | 65.58 | 675 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zc2hc1b | ENSMUSG00000019815 |
| rattus_norvegicus | Zc2hc1b | ENSRNOG00000042705 |
| drosophila_melanogaster | CG30460 | FBGN0050460 |
| drosophila_melanogaster | CG42675 | FBGN0261561 |
| caenorhabditis_elegans | WBGENE00020196 |
Paralogs (3): ZC2HC1A (ENSG00000104427), ZNF474 (ENSG00000164185), ZNF475 (ENSG00000250803)
Protein
Protein identifiers
Zinc finger C2HC domain-containing protein 1B — Q5TFG8 (reviewed: Q5TFG8)
All UniProt accessions (1): Q5TFG8
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the ZC2HC1 family.
RefSeq proteins (1): NP_001013645* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026319 | ZC2HC1A/B-like | Family |
| IPR049899 | Znf_C2HC_C3H | Domain |
Pfam: PF13913
UniProt features (10 total): binding site 4, zinc finger region 2, region of interest 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TFG8-F1 | 74.42 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4): 18; 21; 33; 37
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
PAX3_TARGET_GENES, MIR2052, MIR3140_3P, MIR155_5P, MIR6865_5P, MIR6815_5P, MIR6772_5P, GSE13306_TREG_VS_TCONV_DN, GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN, DESCARTES_MAIN_FETAL_SATELLITE_CELLS, GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN, chr6q24, GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN, GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN, GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN
GO Biological Process (0):
GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
194 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZC2HC1B | FAM163B | P0C2L3 | 735 |
| ZC2HC1B | SEC22C | Q9BRL7 | 666 |
| ZC2HC1B | ZDHHC22 | Q8N966 | 646 |
| ZC2HC1B | LRRTM2 | O43300 | 508 |
| ZC2HC1B | ZNF496 | Q96IT1 | 439 |
| ZC2HC1B | TSC22D4 | Q9Y3Q8 | 419 |
| ZC2HC1B | PHACTR2 | O75167 | 384 |
| ZC2HC1B | SF3B5 | Q9BWJ5 | 372 |
| ZC2HC1B | PLAGL1 | Q9UM63 | 372 |
| ZC2HC1B | LTV1 | Q96GA3 | 365 |
| ZC2HC1B | YJEFN3 | A6XGL0 | 348 |
| ZC2HC1B | RNF145 | Q96MT1 | 345 |
| ZC2HC1B | ADAT2 | Q7Z6V5 | 342 |
| ZC2HC1B | FUCA2 | Q9BTY2 | 323 |
| ZC2HC1B | ACADS | P16219 | 323 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NCK2 | ZC2HC1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| NFKBID | ZC2HC1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| GABPA | ZC2HC1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZC2HC1B | NFKBID | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZC2HC1B | ZGPAT | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZC2HC1B | CASTOR1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZC2HC1B | TUFM | psi-mi:“MI:0915”(physical association) | 0.400 |
| CFTR | ZC2HC1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| CACNG1 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| REP15 | MCM3AP | psi-mi:“MI:0914”(association) | 0.350 |
| OR2M7 | MARCHF6 | psi-mi:“MI:0914”(association) | 0.350 |
| ZC2HC1B | TUBB4A | psi-mi:“MI:0914”(association) | 0.350 |
| OR52K2 | ZC2HC1B | psi-mi:“MI:0914”(association) | 0.350 |
| ZGPAT | ZC2HC1B | psi-mi:“MI:0915”(physical association) | 0.000 |
| GABPA | ZC2HC1B | psi-mi:“MI:0915”(physical association) | 0.000 |
| CASTOR1 | ZC2HC1B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (27): ZC2HC1B (Two-hybrid), GABPA (Two-hybrid), NFKBID (Two-hybrid), ZGPAT (Two-hybrid), GATSL3 (Two-hybrid), ZC2HC1B (Proximity Label-MS), ZC2HC1B (Affinity Capture-MS), ZC2HC1B (Affinity Capture-MS), TUBB4A (Affinity Capture-MS), TUBB4B (Affinity Capture-MS), TUBB (Affinity Capture-MS), TUBB8 (Affinity Capture-MS), ZC2HC1B (Affinity Capture-MS), ZC2HC1B (Affinity Capture-MS), TUBB2A (Affinity Capture-MS)
ESM2 similar proteins: A0JMZ1, A1L209, A1L2F3, A1L3I5, A2AWT3, A4FUE7, A6QQM4, O82171, O94519, P97868, Q08AZ1, Q14CW9, Q1W1G1, Q22122, Q2HJG4, Q2YDJ0, Q32KN7, Q5EAW4, Q5PPV5, Q5REC0, Q5TFG8, Q5ZMS6, Q618K0, Q62920, Q64GL0, Q66HC1, Q6DGN6, Q6NRP6, Q6P1U3, Q6V5K9, Q7SXT7, Q7Z6E9, Q801E2, Q8BJH1, Q8CI51, Q8H100, Q8IMP6, Q8IYB5, Q8R550, Q91W18
Diamond homologs: A4FUE7, Q22122, Q32KN7, Q53FD0, Q5PPV5, Q5REC0, Q5TFG8, Q618K0, Q6AYP4, Q7SXT7, Q8BJH1, Q8CCG1, Q96GY0, Q9BGW4, Q9D534, Q5R498
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 32 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1460 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:143886031:GGAAA:G | acceptor_gain | 1.0000 |
| 6:143886147:CCAAG:C | donor_loss | 1.0000 |
| 6:143886148:CAAGG:C | donor_loss | 1.0000 |
| 6:143886149:AAGGT:A | donor_loss | 1.0000 |
| 6:143886150:AG:A | donor_loss | 1.0000 |
| 6:143886151:GG:G | donor_loss | 1.0000 |
| 6:143886152:GT:G | donor_loss | 1.0000 |
| 6:143886153:T:A | donor_loss | 1.0000 |
| 6:143886757:GT:G | donor_gain | 1.0000 |
| 6:143898545:C:G | acceptor_gain | 1.0000 |
| 6:143898550:A:AG | acceptor_gain | 1.0000 |
| 6:143898551:G:GA | acceptor_gain | 1.0000 |
| 6:143898551:GATT:G | acceptor_gain | 1.0000 |
| 6:143903043:GGGTA:G | acceptor_gain | 1.0000 |
| 6:143903148:GTCAG:G | donor_gain | 1.0000 |
| 6:143903150:CAGG:C | donor_loss | 1.0000 |
| 6:143903150:CAGGT:C | donor_loss | 1.0000 |
| 6:143903152:GGT:G | donor_loss | 1.0000 |
| 6:143903153:GT:G | donor_loss | 1.0000 |
| 6:143903153:GTG:G | donor_loss | 1.0000 |
| 6:143903154:T:A | donor_loss | 1.0000 |
| 6:143903154:T:G | donor_loss | 1.0000 |
| 6:143937645:AAAG:A | acceptor_gain | 1.0000 |
| 6:143937646:A:G | acceptor_gain | 1.0000 |
| 6:143867018:GTA:G | donor_gain | 0.9900 |
| 6:143867019:TAT:T | donor_gain | 0.9900 |
| 6:143867020:ATA:A | donor_gain | 0.9900 |
| 6:143886026:TTCTA:T | acceptor_loss | 0.9900 |
| 6:143886028:CTA:C | acceptor_loss | 0.9900 |
| 6:143886029:TA:T | acceptor_loss | 0.9900 |
AlphaMissense
1446 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:143884348:T:C | F25L | 0.925 |
| 6:143884350:T:A | F25L | 0.925 |
| 6:143884350:T:G | F25L | 0.925 |
| 6:143886083:T:C | F48L | 0.887 |
| 6:143886085:C:A | F48L | 0.887 |
| 6:143886085:C:G | F48L | 0.887 |
| 6:143898584:T:C | F128L | 0.777 |
| 6:143898586:T:A | F128L | 0.777 |
| 6:143898586:T:G | F128L | 0.777 |
| 6:143898647:T:C | F149L | 0.766 |
| 6:143898649:T:A | F149L | 0.766 |
| 6:143898649:T:G | F149L | 0.766 |
| 6:143898617:T:C | F139L | 0.754 |
| 6:143898619:C:A | F139L | 0.754 |
| 6:143898619:C:G | F139L | 0.754 |
| 6:143886062:T:C | F41L | 0.749 |
| 6:143886064:C:A | F41L | 0.749 |
| 6:143886064:C:G | F41L | 0.749 |
| 6:143884349:T:C | F25S | 0.710 |
| 6:143886709:G:C | W79C | 0.707 |
| 6:143886709:G:T | W79C | 0.707 |
| 6:143884349:T:G | F25C | 0.695 |
| 6:143884344:A:C | R23S | 0.687 |
| 6:143884344:A:T | R23S | 0.687 |
| 6:143886728:T:C | F86L | 0.676 |
| 6:143886730:T:A | F86L | 0.676 |
| 6:143886730:T:G | F86L | 0.676 |
| 6:143886103:A:C | R54S | 0.647 |
| 6:143886103:A:T | R54S | 0.647 |
| 6:143886048:T:A | I36K | 0.636 |
dbSNP variants (sampled 300 via entrez): RS1000012741 (6:143913438 C>T), RS1000019628 (6:143916933 G>A,C), RS1000080719 (6:143925974 T>G), RS1000083456 (6:143880718 A>G), RS1000119260 (6:143927045 G>A,C,T), RS1000133848 (6:143887628 A>G), RS1000182367 (6:143887114 A>G), RS1000206287 (6:143931469 T>C,G), RS1000241657 (6:143918796 A>G,T), RS1000361289 (6:143876747 G>A), RS1000361872 (6:143893831 C>T), RS1000433487 (6:143938107 A>G), RS1000449459 (6:143864622 C>G), RS1000466911 (6:143883960 G>A), RS1000475693 (6:143885404 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002594_29 | Neurofibrillary tangles | 3.000000e-06 |
| GCST007637_43 | Diffusing capacity of carbon monoxide | 4.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006797 | neurofibrillary tangles measurement |
| EFO:0009369 | diffusing capacity of the lung for carbon monoxide |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| Nickel | decreases expression | 2 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| Methapyrilene | increases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.